2care4 Generics ApS
Credit rating
Company information
About 2care4 Generics ApS
2care4 Generics ApS (CVR number: 36960566) is a company from ESBJERG. The company recorded a gross profit of 73.4 mDKK in 2023. The operating profit was 41.2 mDKK, while net earnings were 31.6 mDKK. The profitability of the company measured by Return on Assets (ROA) was 26.1 %, which can be considered excellent and Return on Equity (ROE) was 39.3 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 50.8 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. 2care4 Generics ApS's liquidity measured by quick ratio was 1.2 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | |||||
Gross profit | -77.00 | 32 852.00 | 55 863.00 | 75 691.00 | 73 414.00 |
EBIT | -77.00 | 19 182.00 | 36 160.00 | 44 649.00 | 41 160.00 |
Net earnings | - 599.00 | 15 715.00 | 29 083.00 | 34 598.00 | 31 564.00 |
Shareholders equity total | - 166.00 | 15 549.00 | 44 632.00 | 74 230.00 | 86 544.00 |
Balance sheet total (assets) | 35 417.00 | 72 433.00 | 127 774.00 | 170 991.00 | 170 370.00 |
Net debt | 35 099.00 | 44 344.00 | |||
Profitability | |||||
EBIT-% | |||||
ROA | -0.3 % | 35.5 % | 36.1 % | 30.9 % | 26.1 % |
ROE | -447.6 % | 204.3 % | 96.7 % | 58.2 % | 39.3 % |
ROI | -0.3 % | 35.5 % | 36.1 % | 35.1 % | 32.3 % |
Economic value added (EVA) | 385.27 | 19 190.34 | 35 378.66 | 32 649.86 | 30 538.26 |
Solvency | |||||
Equity ratio | 100.0 % | 100.0 % | 43.4 % | 50.8 % | |
Gearing | 70.0 % | 51.7 % | |||
Relative net indebtedness % | |||||
Liquidity | |||||
Quick ratio | 1.2 | 1.2 | |||
Current ratio | 1.6 | 1.8 | |||
Cash and cash equivalents | 16 897.00 | 438.00 | |||
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | |||||
Credit risk | |||||
Credit rating | BB | BB | BBB | AA | AA |
Variable visualization
Roles
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.